ClinicalTrials.gg
RecruitingNCT07731776ENDO-RMUpdated Jul 30, 2026

Improving Access to Pelvic Health Physiotherapy for Endometriosis

An observational study in Endometriosis, sponsored by Université de Sherbrooke. Recruiting at 1 site in Canada. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-07-30.

Sponsored by Université de Sherbrooke · Observational

From the registry’s dates

  • Started Jul 2026; still recruiting 3 months later.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
264
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This is a mixed-methods study aimed to generate new evidence to help optimize access to pelvic health physiotherapy (PHPT) for women living with endometriosis in the province of Quebec (Canada). Specifically, the objectives are to:

Obj. 1: Understand the patient journey of women living with endometriosis, including their experiences accessing PHPT.

Obj. 2: Describe current PHPT clinical practices and service delivery for women living with endometriosis in Quebec.

Obj. 3: Identify barriers, facilitators and potential strategies to improve access to PHPT services and optimize the patient journey of women living with endometriosis in Quebec.

Findings will inform clinical, organizational and policy recommendations to strengthen the integration of PHPT within multidisciplinary endometriosis care. The project is divided into three sequential parts:

Part 1: Semi-structured individual interviews (open-ended questions) will be conducted with women living with endometriosis to explore their journey to obtain endometriosis care, experiences accessing PHPT and perceived barriers and facilitators. Approximately 15-20 participants will be recruited until data saturation is reached.

Part 2: An online cross-sectional survey will be conducted among pelvic health physiotherapists practicing in the province of Quebec, Canada to describe current clinical practices, service delivery and challenges related to the management of women living with endometriosis. The minimum expected sample size is 225 physiotherapists .

Part 3: Semi-structured focus groups (open-ended questions) will be conducted with women living with endometriosis, pelvic health physiotherapists, physicians and healthcare managers to identify and prioritize strategies to improve access to PHPT services. Approximately 24-32 participants will be recruited across four focus groups.

Across all three parts, recruitment strategies will aim to ensure diversity in participant characteristics, including geographic region, sociodemographic characteristics and healthcare experiences, to capture a broad range of perspectives.

Read the detailed description

This study uses a mixed-methods design consisting of three complementary components: (1) qualitative semi-structured interviews, (2) a cross-sectional online survey, and (3) qualitative focus groups.

02

Conditions studied

  • Endometriosis

Browse trials for

Keywords

  • Women's Health
  • Chronic Pelvic Pain
  • Endometriosis
  • Patient Navigation
  • Delivery of Health Care
  • Healthcare Access
  • Pelvic Health
03

In context

Endometriosis

920 studies on the registry are indexed under Endometriosis; 266 are open to participants now.

This study's planned enrollment of 264 is above the median of 135 across 349 observational studies indexed under Endometriosis.

Browse Endometriosis studies →

Lead sponsor

Université de Sherbrooke is the lead sponsor of 295 studies on the registry; 65 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Part 1 will include women living with confirmed or suspected endometriosis in Quebec, Canada. Part 2 will include pelvic health physiotherapists practicing in Quebec, Canada who provide care to women with confirmed or suspected endometriosis. Part 3 will include women living with confirmed or suspected endometriosis, healthcare professionals and healthcare managers involved in the organization, delivery or support of endometriosis care in the province of Quebec.

Eligibility criteria

Inclusion Criteria (part 1):

  • Female (biological sex at birth)
  • Aged between 18 and 45 years old
  • Residing in the province of Quebec, Canada
  • Able to speak and understand French
  • Has a confirmed or suspected diagnosis of endometriosis

Inclusion Criteria (part 2):

  • Licensed physiotherapist authorized to practice pelvic health physiotherapy in Quebec, Canada
  • Currently practicing in the province of Quebec, Canada
  • Provides pelvic health physiotherapy services to women experiencing symptoms associated with endometriosis

Inclusion Criteria (part 3):

Women living with endometriosis:

  • Female (biological sex at birth)
  • Aged between 18 and 45 years old
  • Residing in the province of Quebec, Canada
  • Able to speak and understand French
  • Has a confirmed or suspected diagnosis of endometriosis

Healthcare providers/managers:

- Has experience providing, coordinating, organizing or managing care for women with confirmed or suspected endometriosis in the province of Quebec, Canada

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
264 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Patient journey and experiences of women living with endometriosis

    Patient journey, healthcare experiences and use of pelvic health physiotherapy will be explored through semi-structured individual interviews with women living with endometriosis.

    Time frame: Baseline

  2. Barriers to accessing pelvic health physiotherapy

    Assessed through the online survey, semi-structured individual interviews and group discussion with patients living with endometriosis, healthcare providers and healthcare managers.

    Time frame: Baseline

  3. Facilitators to accessing pelvic health physiotherapy

    Assessed through the online survey, semi-structured individual interviews and group discussion with patients living with endometriosis, healthcare providers and healthcare managers.

    Time frame: Baseline

  4. Pelvic health physiotherapy clinical practices and service delivery

    Assessed through the online survey.

    Time frame: Baseline

  5. Recommendations to improve access to pelvic health physiotherapy

    Assessed through the online survey and focus group discussion with patients, healthcare providers and healthcare managers.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Due to the sensitive information collected, individual participant data will not be shared in order to protect participant confidentiality. Study findings will be reported in aggregate form through scientific publications and presentations.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2026 (actual). Primary completion is estimated for Mar 2027, 8 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 23, 2026
First posted
Jul 28, 2026
StartActual
Jul 28, 2026
Primary completionEst.
Mar 29, 2027
CompletionEst.
Mar 29, 2027
Last update
Jul 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07731776
Collaborators
Réseau Québécois de Recherche sur la Douleur (RQRD), Association Québécoise de la Physiothérapie (AQP)
Responsible party
Mélanie Morin (PT, PhD, Full professor, Researcher, Director of the Pelvic Health Research Laboratory, Tier 1 Canada Research Chair in Women's pelvic health, Faculty of Medicine and Health Sciences, University of Sherbrooke and Research Centre of the CHUS, Université de Sherbrooke) — Principal investigator
First posted
Jul 28, 2026
Start date
Jul 28, 2026
Primary completion
Mar 29, 2027 (estimated)
Completion
Mar 29, 2027 (estimated)
Last update
Jul 30, 2026

Study contacts

Rose-Marie Bourget, PT, Master's student
Contact
accesphysioperineale@usherbrooke.ca
1-888-463-1835 ext. 18439
Camille Simard, MSc
Contact
labomorin@usherbrooke.ca
1-819-821-8000 ext. 18439
Mélanie Morin, PhD, PT
principal investigator · Full professor, Researcher, Director of the Pelvic Health Research Laboratory, Canada Research Chair in Women's pelvic health, Faculty of Medicine and Health Sciences, University of Sherbrooke and Research Centre of the CHUS

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion